We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
1151
HubSpot
HUBS
$12.7B
-17,815
Closed -$4.81M
HYLN icon
1152
Hyliion Holdings
HYLN
$729M
-16,614
Closed -$48K
IART icon
1153
Integra LifeSciences
IART
$1.39B
-84,848
Closed -$3.59M
ICAD
1154
DELISTED
iCAD Inc
ICAD
-13,783
Closed -$29K
ICE icon
1155
Intercontinental Exchange
ICE
$83.8B
-76,520
Closed -$6.91M
ICL icon
1156
ICL Group
ICL
$6.65B
-44,398
Closed -$363K
IDXX icon
1157
Idexx Laboratories
IDXX
$46.4B
-9,365
Closed -$3.05M
IFF icon
1158
International Flavors & Fragrances
IFF
$20.7B
-10,547
Closed -$958K
III icon
1159
Information Services Group
III
$210M
-14,337
Closed -$68K
IONS icon
1160
Ionis Pharmaceuticals
IONS
$9.15B
-10,766
Closed -$476K
IOSP icon
1161
Innospec
IOSP
$2.14B
-8,029
Closed -$688K
IR icon
1162
Ingersoll Rand
IR
$34.7B
-5,693
Closed -$246K
IRWD icon
1163
Ironwood Pharmaceuticals
IRWD
$709M
-173,082
Closed -$1.79M
ISRG icon
1164
Intuitive Surgical
ISRG
$130B
-25,226
Closed -$4.73M
ITT icon
1165
ITT
ITT
$18.3B
-10,174
Closed -$665K
JHG
1166
DELISTED
Janus Henderson
JHG
-89,581
Closed -$1.82M
JNPR
1167
DELISTED
Juniper Networks
JNPR
-19,605
Closed -$512K
KBR icon
1168
KBR
KBR
$4.77B
-23,524
Closed -$1.02M
KEY icon
1169
KeyCorp
KEY
$24.8B
-70,019
Closed -$1.12M
KMT icon
1170
Kennametal
KMT
$2.75B
-120,551
Closed -$2.48M
KN icon
1171
Knowles
KN
$3.45B
-153,032
Closed -$1.86M
KNTK icon
1172
Kinetik
KNTK
$3.58B
-17,201
Closed -$560K
KO icon
1173
Coca-Cola
KO
$372B
-35,521
Closed -$1.99M
KOD icon
1174
Kodiak Sciences
KOD
$2.68B
-93,371
Closed -$723K
KRNY icon
1175
Kearny Financial
KRNY
$613M
-36,247
Closed -$385K

Similar funds

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.